Alzamend Neuro starts Phase 2 trial of AL001 with novel coil tech to test improved lithium delivery in the brain for multiple ...

A novel cannula delivery system has been developed to enhance multiphoton microscopy by enabling the direct administration of imaging agents and drugs to the brain, bypassing the blood-brain barrier.

QMENTA's AI platform will streamline imaging analysis and ensure regulatory compliance during all trials. Alzamend to launch five Phase 2 trials of AL001, including PTSD and bipolar disorder ...

The imaging findings revealed decreases in excitatory neurotransmitters, which are normally increased in bipolar disorder.

In a groundbreaking study in Biological Psychiatry, published by Elsevier, researchers report significant strides in enhancing early diagnosis of bipolar disorder in adolescents. They demonstrate ...